Nonprofit, nonpartisan journalism. Supported by readers.


Dayton names 16 to the new Minnesota Task Force on Medical Cannabis Therapeutic Research

The task force will monitor Minnesota’s new medical marijuana law, which is restricted to use for a few serious ailments and doesn’t allow smoking.

Gov. Mark Dayton has appointed 16 members of a task force that will monitor the state’s new medical marijuana law.

The Task Force on Medical Cannabis Therapeutic Research is part of the bill passed by the Legislature that allows use of medical marijuana for a small number of serious medical conditions, but doesn’t allow smoking.

The task force members include four patients (consumers) or their parents, four law enforcement representatives, four substance abuse treatment providers and four health care providers.

Terms for all members run through Jan. 5, 2015:

  1. James Backstrom – Hastings, Minnesota County Attorneys Association Representative
  2. Duane Bandel – Minneapolis, Consumer Member
  3. Maria Botker – Clinton, Parent Member
  4. Dennis Flaherty – St. Paul, Minnesota Police and Peace Officers Association Representative
  5. Karina Forrest – White Bear Township, Substance Use Treatment Provider
  6. James Franklin – St. Paul, Minnesota Sheriff’s Association Representative
  7. Dr. Pamela Gonzalez – Minneapolis, Substance Use Treatment Provider
  8. David Hartford – St. Cloud, Substance Use Treatment Provider
  9. Dr. Vincent Hayden – Minneapolis, Substance Use Treatment Provider
  10. Chief David Kolb – Champlin, Minnesota Chiefs of Police Association Representative
  11. Doreen McIntyre – Champlin, Health Care Provider
  12. Jeremy Pauling – Montevideo, Parent Member
  13. Dr. Charles Reznikoff – Minneapolis, Health Care Provider
  14. Laura Schwartzwald – Aitkin, Pharmacist Member
  15. Sarah Wellington –St. Paul, Consumer Member
  16. Dr. Dawn Wyllie – Bemidji, Health Care Provider

Two legislators and the state commissioners of Health, Human Services and Public Safety will also be on the task force.